Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210242) titled 'HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR' on Sept. 29.
Study Type: Observational [Patient Registry]
Primary Sponsor: Ting YANG
Condition:
Cytomegalovirus Infections
Hematopoietic Stem Cell Transplantation
Virus Reactivation
Graft vs Host Disease
Recruitment Status: Not recruiting
Date of First Enrollment: October 10, 2025
Target Sample Size: 300
To know more, visit https://clinicaltrials.gov/study/NCT07210242
Disclaimer: Curated by HT Syndication....